6934 — Hcmed Innovations Co Income Statement
0.000.00%
Last trade - 00:00- TWD4.24bn
- TWD4.06bn
- TWD141.61m
Annual income statement for Hcmed Innovations Co, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 54.1 | 6.48 | 9.23 | 142 |
| Cost of Revenue | ||||
| Gross Profit | 34.6 | -30.8 | -26.1 | 99.7 |
| Selling / General / Administrative Expenses | ||||
| Research And Development | ||||
| Unusual Expense / Income | ||||
| Total Operating Expenses | 92.5 | 152 | 176 | 196 |
| Operating Profit | -38.4 | -146 | -167 | -54.7 |
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | -40.2 | -144 | -166 | -50.9 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -40.2 | -144 | -166 | -78.2 |
| Net Income Before Extraordinary Items | ||||
| Net Income | -40.2 | -144 | -166 | -78.2 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -40.2 | -144 | -166 | -78.2 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -1.41 | -4.76 | -4.99 | -2.22 |
| Dividends per Share |